OPHG Publications 1997-2009

2009
  1. Bellcross CA, Lemke AA, Pape LS, Tess AL, Meisner LT. Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography populationexternal icon Genet Med 2009 Nov;11(11):783-9.
  2. Berg AO, Armstrong K, Botkin J, Calonge N, Haddow J, Hayes M, Kaye C, Phillips KA, Piper M, Richards CS, Scott JA, Strickland OL, Teutsch S. Recommendations from the EGAPP™ Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?external icon Genet Med. 2009 Jan;11(1):15-20.
  3. Berg AO, Armstrong K, Botkin J, Calonge N, Haddow J, Hayes M, Kaye C, Phillips KA, Piper M, Richards CS, Scott JA, Strickland OL, Teutsch S. Recommendations from the EGAPP™ Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.external icon Genet Med. 2009 Jan;11(1):35-41.
  4. Berg AO, Armstrong K, Botkin J, Calonge N, Haddow J, Hayes M, Kaye C, Phillips KA, Piper M, Richards CS, Scott JA, Strickland OL, Teutsch S. Recommendations from the EGAPP™ Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?external icon Genet Med. 2009 Jan;11(1):66-73.
  5. Burton PR, Hansell AL, Fortier I, Manolio TA, Khoury MJ, Little J, Elliott P. Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology.external icon Int J Epidemiol.2009 Feb;38(1):263-73.
  6. Chang MH, Lindegren ML, Butler MA, Chanock SJ, Dowling NF, Gallagher M, Moonesinghe R, Moore CA, Ned RM, Reichler MR, Sanders CL, Welch R, Yesupriya A, Khoury MJ; CDC/NCI NHANES III Genomics Working Group. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.external icon Am J Epidemiol. 2009 Jan 1;169(1):54-66.
  7. Dowling N, Gwinn M, Mawie, A. Human genomics and preparedness for infectious threatsexternal icon. Genome Medicine2009 Dec. 29; 1(12):119.
  8. Goddard KA, Duquette D, Zlot A, Johnson J, Annis-Emeott A, Lee PW, Bland MP, Edwards KL, Oehlke K, Giles RT, Rafferty A, Cook ML, Khoury MJ. Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006external icon. Am J Public Health. 2009 Mar;99(3):442-5.
  9. Goddard KA, Robitaille J, Dowling NF, Parrado AR, Fishman J, Bradley LA, Moore CA, Khoury MJ. Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis.external icon Public Health Genomics. 2009;12(2):92-104.
  10. Grosse SD, McBride CM, Evans JP, Khoury MJ. Personal utility and genomic information: Look before you leapexternal icon Genet Med. 2009 Aug;11(8):575-576.
  11. Guessous I, Gwinn M, Khoury MJ., Genome-wide association studies in pharmacogenomics: untapped potential for translationexternal icon. Genome Med. 2009 Apr 28;1(4):46.
  12. Guessous I, Gwinn M, Yu W, Yeh J, Clyne M, Khoury MJ. Trends in pharmacogenomic epidemiology: 2001-2007external icon. Public Health Genomics. 2009;12(3):142-8.
  13. Gwinn M, Guessous I, Khoury MJ. Invited commentary: genes, environment, and hybrid vigor.external icon Am J Epidemiol. 2009 Sep 15;170(6):703-7.
  14. Gwinn M, Khoury MJ. Principles of human genome epidemiology.external icon Book chapter in: Genomic and Personalized Medicine (2009).
  15. Janssens AC, González-Zuloeta Ladd AM, López-Léon S, Ioannidis JP, Oostra BA, Khoury MJ, van Duijn CM. An empirical comparison of meta-analyses of published gene-disease associations versus consortium analysesexternal icon. Genet Med. 2009 Mar;11(3):153-62.
  16. Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O’Brien TR, Seminara D, Vineis P, Winn DM, Yu W, Ioannidis JP. Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseasesexternal icon. Am J Epidemiol. 2009 Aug 1;170(3):269-79.
  17. Khoury MJ, Bowen S, Bradley LA, Coates RJ, Dowling NF, Gwinn M, Kolor K, Moore CA, St Pierre J, Valdez R, Yoon PW. A decade of public health genomics in the United States: Centers for Disease Control and Prevention 1997-2007external icon. Pub Health Genomics 2009;12:20-29.
  18. Khoury MJ, Feero WG, Reyes M, Citrin T, Freedman A, Leonard D, Burke W, Coates R, Croyle R, Edwards K, Kardia S, McBride C, Manolio T, Randhawa G, Rasooly R, St Pierre J, Terry S; GAPPNet™ Planning Group. The Genomic Applications in Practice and Prevention Networkexternal icon. Genet Med. 2009 Jul;11(7):488-94.
  19. Khoury MJ, Gwinn M. Why do we need public health in the era of genomic medicine?external icon Book chapter. Genomic and Personalized Medicine (2009).
  20. Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J. The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshopexternal icon. Genet Med. 2009 Aug;11(8):559-67.
  21. Khoury MJ, Rich EC, Randhawa G, Teutsch SM, Niederhuber J. Comparative effectiveness research and genomic medicine: An evolving partnership for 21st century medicineexternal icon. Genet Med. 2009 Oct;11(10):707-11
  22. Khoury MJ, Wacholder S. Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies–challenges and opportunitiesexternal icon. Am J Epidemiol. 2009 Jan 15;169(2):227-30; discussion 234-5.
  23. Kim C, Liu T, Valdez R, Beckles GL. Does frank diabetes in first-degree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or nongestational diabetes?external icon Am J Obstet Gynecol. 2009 Dec;201(6):576.e1-6.
  24. Kolor K, Liu T, St. Pierre J, Khoury MJ. Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008external icon. Letter to the Editor in Genet Med. 2009 Aug;11(8): 595.
  25. Krieg EF Jr, Butler MA, Chang MH, Liu T, Yesupriya A, Lindegren ML, Dowling N; for the CDC/NCI NHANES III Genomics Working Group. Lead and cognitive function in ALAD genotypes in the third National Health and Nutrition Examination Surveyexternal icon. Neurotoxicol Teratol. 2009 Nov-Dec;31(6):364-71.
  26. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N. STrengthening the REporting of Genetic Association Studies (STREGA)–an extension of the STROBE statement.external icon Genet Epidemiol. 2009 Nov;33(7):581-98.
  27. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart AF, Birkett N. STrengthening the REporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement.external icon J Clin Epidemiol. 2009 Jun;62(6):597-608.e4.
  28. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement.external icon PLoS Med. 2009 Feb 3;6(2):e22.
  29. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N. STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement.external icon Ann Intern Med. 2009 Feb 3;150(3):206-15.
  30. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement.external icon Eur J Epidemiol. 2009;24(1):37-55.
  31. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement.external icon Hum Genet. 2009 Mar;125(2):131-51.
  32. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N. STrengthening the REporting of Genetic Association studies (STREGA)–an extension of the STROBE statementexternal icon. Eur J Clin Invest. 2009 Apr;39(4):247-66.
  33. Liu T, Valdez R, Yoon PW, Crocker D, Moonesinghe R, Khoury MJ. The association between family history of asthma and the prevalence of asthma among US adults: National Health and Nutrition Examination Survey, 1999 – 2004external icon. Genet Med 2009 May;11(5):323-8.
  34. Mvundura M, McGruder H, Khoury MJ, Valdez R, Yoon PW. Family History as a Risk Factor for Early-Onset Stroke/Transient Ischemic Attack among Adults in the United Statesexternal icon. Public Health Genomics. 2009 Mar 23.
  35. O’Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT 4th; Familial risk for common diseases in primary care: the Family Healthware Impact Trialexternal icon. Family Healthware Impact Trial group. Am J Prev Med. 2009 Jun;36(6):506-14.
  36. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP™ supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeexternal icon. Genet Med. 2009 Jan;11(1):42-65.
  37. Palomaki GE, Bradley LA, Douglas MP, Kolor K, Dotson WD. Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based reviewexternal icon. Genet Med. 2009 Jan;11(1):21-34.
  38. Robitaille J, Hamner HC, Cogswell ME, Yang Q. Does the MTHFR 677C–>T variant affect the Recommended Dietary Allowance for folate in the US population?external icon Am J Clin Nutr. 2009 Apr;89(4):1269-73.
  39. Rogowski WH, Grosse SD, Khoury MJ. Challenges of translating genetic tests into clinical and public health practiceexternal icon. Nat Rev Genet. 2009 Jul;10(7):489-95.
  40. Scheuner MT and Yoon PW. Family History: A Bridge Between Genomic Medicine and Disease Prevention.external icon In: Genomic and Personalized Medicine . Willard H, Ginsburg G, eds. New York: ELSEVIER (2009).
  41. Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO, Chair, on behalf of the EGAPP™ Working Group. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP™) initiative: methods of the EGAPP™ Working Groupexternal icon. Genet Med. 2009 Jan;11(1):3-14.
  42. Valdez R. Detecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Toolpdf icon[PDF 282 KB]external icon. J Diabetes Sci Technol. 2009 Jul; 3(4):722-26.
  43. Wang C, O’Neill SM, Rothrock N, Gramling R, Sen A, Acheson LS, Rubinstein WS, Nease DE Jr, Ruffin MT 4th; Comparison of risk perceptions and beliefs across common chronic diseasesexternal icon. Family Healthware Impact Trial (FHITr) group. Prev Med. 2009 Feb;48(2):197-202.
  44. Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer careexternal icon. Public Health Genomics. 2009;12(4):233-44.
  45. Yang Q, Flanders WD, Moonesinghe R, Ioannidis JP, Guessous I, Khoury MJ. Using Lifetime Risk Estimates in Personal Genomic Profiles: Estimation of Uncertainty.external icon Am J Hum Genet. 2009 Dec;85(6):786-800.
  46. Yesupriya A, Gwinn M, Khoury MJ. Comment: Building a knowledge base on genetic variation and cancer risk through field synopsesexternal icon. J Natl Cancer Inst. 2009 Jan 7;101(1):4-5.
  47. Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ. Developing Family Healthware, a family history screening tool to prevent common chronic diseasesexternal icon. Prev Chronic Dis. 2009 Jan;6(1):A33.
  48. Yu W, Ned R, Wulf A, Liu T, Khoury MJ, Gwinn M. The need for genetic variant naming standards in published abstracts of human genetic association studies.external icon BMC Res Notes. 2009 Apr 14; 2:56.
  49. Zhang L, Katz JM, Gwinn M, Dowling NF, Khoury MJ. Systems-based candidate genes for human response to influenza infectionexternal icon. Infect Genet Evol. 2009 Dec;9(6):1148-57.
     Top of Page

     

    2008
  50. Agurs-Collins T, Khoury MJ, Simon-Morton D, Olster DH, Harris JR, Milner JA. Public health genomics: translating obesity genomics research into population health benefitsexternal icon. Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S85-94.
  51. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene databaseexternal icon. Nat Genet. 2008 Jul;40(7):827-34.
  52. Baron RC, Rimer BK, Breslow RA, Coates, RJ, Kerner J, Melillo S, Habarta N, Kalra GP, Chattopadhyay S, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA, and the Task Force on Community Preventive Services. Client-Directed Interventions to Increase community demand for breast, cervical, and colorectal cancer screening a systematic reviewexternal icon. Am J Prev Med. 2008 Jul;35(1 Suppl):S34-55.
  53. Baron RC, Rimer BK, Coates RJ, Kerner J, Kalra GP, Melillo S, Habarta N, Wilson KM, Chattopadhyay S, Leeks K, and the Task Force on Community Preventive Services. Client-Directed Interventions to Increase Community Access to Breast, Cervical, and colorectal cancer screening a systematic reviewexternal icon. Am J Prev Med. 2008 Jul;35(1 Suppl):S56-66.
  54. Baron RC, Rimer BK, Coates, RJ, Kerner J, Mullen PD, Chattopadhyay S, Briss PA, and the Task Force on Community Preventive Services. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers.external icon Am J Prev Med. 2008 Jul;35(1 Suppl):S26-33.
  55. Breslow RA, Rimer BK, Baron RC, Coates RJ, Kerner J, Wilson KM, Lee NC, Mullen PD, Coughlin SS, and Briss PA. Introducing the Community Guide’s Reviews of Evidence on Interventions to Increase Screening for Breast, Cervical, and Colorectal Cancers.external icon Am J Prev Med. 2008 Jul;35(1 Suppl):S14-20.
  56. Coates RJ, Khoury MJ, Gwinn M. (editorial) Five Genetic Variants Associated with Prostate Cancer.external icon N Engl J Med 2008 Jun 19;358(25):2738; author reply 2741
  57. Coates RJ, Kolor K, Stewart SL, Richardson LC. Diagnostic markers for ovarian cancer screening: not ready for routine clinical useexternal icon. Letter. Clin Cancer Res 20082008 Nov 15;14(22):7575-6; author reply 7577-9.
  58. Gwinn M, Guessous I, Khoury M. Intention to analyze in pharmacogenomics studies.external icon Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):740; author reply 740-1. No abstract available.
  59. Hunter D, Khoury MJ, Drazen JM. Letting the genome out of the bottle – will we get our wish?external icon N Engl J Med 2008 Jan 10;358(2):105-7.
  60. Ioannidis JP, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ. Assessment of cumulative evidence on genetic associations: interim guidelines.external icon Int J Epidemiol. 2008 Feb;37(1):120-32.
  61. Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions.external icon Am J Hum Genet. 2008 Mar;82(3):593-9.
  62. Kavvoura FK, McQueen MB, Khoury MJ, Tanzi RE, Bertram L, Ioannidis JP. Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer’s disease.external icon Am J Epidemiol. 2008 Oct 15;168(8):855-65.
  63. Khoury MJ, Millikan R, Gwinn ML. Genetic and molecular epidemiology. Chapter In Rothman KJ et al. (eds). Modern Epidemiology, third edition, (2008).
  64. Khoury MJ, Valdez R, Albright A. Public Health Genomics Approach to Type 2 Diabetes.external icon Diabetes 2008 Nov;57(11):2911-2914.
  65. Moonesinghe R, Khoury MJ, Liu T, Ioannidis JPA. Required sample size and non-replicability thresholds for heterogeneous genetic associations.external icon Proceedings of the National Academy of Sciences of the United States of America. 2008 Jan 15;105(2):617-22.
  66. Moonesinghe R, Yang Q, Khoury MJ. Sample size requirements to detect the effect of a group of genetic variants in case-control studiesexternal icon. Emerg Themes Epidemiol. 2008 Dec 3;5:24.
  67. Robitaille J, Yoon PW, Irizarry-Delacruz M, Liu T, Moore CA, Looker AC, Khoury MJ. Prevalence, Family History, and Prevention of Reported Osteoporosis in U.S. Women.external icon Am J Prev Med. 2008 Jul;35(1):47-54.
  68. Sabatino SA, Habarta N, Baron RC, Coates RJ, Rimer BK, Kerner J, Coughlin SS, Kalra GP, Chattopadhyay S, and the Task Force on Community Preventive Services. Interventions to Increase Recommendation and Delivery of Screening for Breast, Cervical, and Colorectal Cancers by Healthcare Providers Systematic Reviews of Provider Assessment and Feedback and Provider Incentives.external icon Am J Prev Med. 2008 Jul;35(1 Suppl):S67-74.
  69. Trivers KF, Shaw KM, Sabatino SA, Shapiro JA, Coates RJ, Trends in Colorectal Cancer Screening Disparities in People Aged 50–64 Years, 2000–2005.external icon Am J Prev Med. 2008 Sep;35(3):185-93.
  70. Yang QH, Botto LD, Gallagher M, Friedman JM, Sanders CL, Koontz D, Nikolova S, Erickson JD, Steinberg K. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bankexternal icon. Am J Clin Nutr 2008 Jul;88(1):232-46.
  71. Yesupriya A, Evangelou E, Kavvoura FK, Patsopoulos NA, Clyne M, Walsh MC, Lin BK, Yu W, Gwinn M, Ioannidis JP, Khoury MJ. Reporting of Human Genome Epidemiology (HuGE) association studies: an empirical assessment.external icon BMC Med Res Methodol. 2008 May 20;8(1):31.
  72. Yesupriya A, Yu W, Clyne M, Gwinn M, Khoury MJ. The continued need to synthesize the results of genetic associations across multiple studies.external icon Genet Med. 2008 Aug;10(8):633-5.
  73. Yu W, Clyne M, Dolan SM, Yesupriya A, Wulf A, Liu T, Khoury MJ, Gwinn M. GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique.external icon BMC Bioinformatics. 2008 Apr 22;9:205.
  74. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ. A navigator for human genome epidemiology.external icon Nat Genet. 2008 Feb;40(2):124-5.
  75. Yu W, Wulf A, Liu T, Khoury MJ, Gwinn M. Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases.external icon BMC Bioinformatics. 2008 Dec 8; 9:528.
  76. Yu W, Wulf A, Yesupriya A, Clyne M, Khoury MJ, Gwinn M. HuGE Watch: tracking trends and patterns of published studies of genetic association and human genome epidemiology in near-real time.external icon Eur J Hum Genet. 2008 Sep;16(9):1155-8.  Top of Page

     

    2007
  77. Austin H, Key N, Benson JM, Lally C, Dowling NF, Whitsett C, Hooper WC. Sickle-cell trait and the risk of venous thromboembolism among African-Americans.external icon Blood 2007 Aug 1;110(3):908-12
  78. Davis RL, Khoury MJ. The emergence of biobanks: practical design considerations for large population-based studies of gene-environment interactions.external icon Comm Genet 2007;10(3):181-5.
  79. De Staercke C, Lally C, Austin H, Winston C, Dowling N, Williams B, Hooper WC. The lack of association between four point mutations in the promoter region of the toll-like 4 receptor gene and myocardial infarction.external icon Thrombosis Research 2007; 119(1):105-1.
  80. El-Serag H, Khoury MJ, Lewis JD. HuGE reviews and meta-analysis of gene association studies.external icon Gastroenterology 2007 Mar;132:839-840.
  81. Evans J, Khoury MJ. Evidence based medicine meets genomic medicineexternal icon. Genet Med. 2007 Dec;9(12):799-800.
  82. Goddard KAB, Moore C, Ottman D, Szegda KL, Bradley L, Khoury MJ. Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006.external icon Genet Med. 2007 Aug;9(8):510-7.
  83. Ferdinands JM, Mannino DM, Gwinn ML, Bray MS. ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study.external icon PLoS One. 2007 Mar 14;2(3):e289.
  84. Gwinn M, Khoury MJ. Dermatology and the human genome: and epidemiologic approach.external icon Arch Dermatology 2007 Sep;143(9):1194-6.
  85. Hariri S, Myers MF, Yoon PW. Attitudes, knowledge, and behaviors regarding genetic testing among women who do and do not meet the USPSTF guidelines for genetic testing for breast and ovarian cancer susceptibility. Submitted Genet Medic.
  86. Higgins JP, Little J, Ioannidis JP, Bray MS, Manolio TA, Smeeth L, Sterne JA,Anagnostelis B, Butterworth AS, Danesh J, Dezateux C, Gallacher JE, Gwinn M,Lewis SJ, Minelli C, Pharoah PD, Salanti G, Sanderson S, Smith LA, Taioli E, Thompson JR, Thompson SG, Walker N, Zimmern RL, Khoury MJ. Turning the pump handle: evolving methods for integrating the evidence on gene-disease associationexternal icon. Am J Epidemiol. 2007 Oct 15;166(8):863-6. Epub 2007 Sep 5.
  87. Honore, P., Simoes, E. J., Moonesinghe, R., Wang, X., Brown, L. Evaluating the Ecological Association of Casino Industry Economic Development on Community Health Status: A Natural Experiment in the Mississippi Delta Region.external icon J Public Health Manag Pract. 2007 Mar-Apr;13(2):214-22.
  88. Janssens ACJW, Moonesinghe R, Yang, Q, Steyerberg EW, van Dujin CM, Khoury MJ. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases.external icon Genet Med. 2007 Aug;9(8):528-35.
  89. Khoury MJ, Berg A, Coates R, Evans J, Teutsch S, Bradley LA. The evidence dilemma in genomic medicine.external icon Health Aff (Millwood). 2008 Nov-Dec;27(6):1600-11.
  90. Khoury MJ, Bradley LA. Why should genomic medicine become more evidence-based?external icon Genomic Med. 2007 1:91-93.
  91. Khoury MJ, Gwinn M, Bowen MS. Genomics and public health research.external icon (letter to the editor) JAMA. 2007 June;297(21):2347.
  92. Khoury MJ, Gwinn M, Burke W, Bowen MS, Zimmern RL. Will Genomics Widen or Heal the Schism Between Medicine and Public Health?external icon AJPM. 2007 Oct;33(4):310-7.
  93. Khoury MJ, Little J, Gwinn M, Ioannidis JP. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies.external icon Int J Epidemiol. 2007 Apr;36(2):439-45.
  94. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley LA. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?external icon Genet Med. 2007 Oct;9(10):665-74.
  95. Khoury MJ, Little J, Higgins J, Ioannidis JP, Gwinn M. Reporting of systematic reviews: the challenge of genetic association studies.external icon PLoS Med. 2007 Jun 26;4(6):e211.
  96. Khoury MJ, Little J, Higgins J, Ioannidis JP, Gwinn M. The need for high quality systematic reviews and meta analyses of genetic associations. (letter to the editor) PLoS Medicine. 2007 (April 16).
  97. Moonesinghe R, Khoury MJ, Jansenns AJW. Most published research findings are false – but a little replication goes a long way.external icon PLoS Medicine 2007 Feb;4(2):e28:218-220.
  98. Rebbeck TR, Khoury MJ, Potter JD. Genetic association studies of cancer: where do we go from here?external icon CEBP. 2007 May;16(5):864-5.
  99. Seminara D, Khoury MJ, O’Brien T et al. The emergence of networks in human genome epidemiology: challenges and opportunities.external icon Epidemiology 2007 Jan;18(1):1-8.
  100. Valdez R, Greenlund KJ, Khoury MJ, Yoon PW. Is family history a useful tool to detect children at risk for chronic disease and to enrich prevention campaigns aimed at the pediatric population.external icon Pediatrics 2007 Sep;120 Suppl 2:S78-86.
  101. Valdez R, Yoon PW, Liu T, Khoury MJ. Family history and prevalence of diabetes in the US population: 6-year results from the National Health and Nutrition Examination Survey (NHANES, 1999-2004).external icon Diabetes Care. October 2007; 30 (10):2517-22.
  102. Yu W, Yesupriya A, Wulf A, Qu J, Gwinn M, Khoury MJ. An automatic method to generate domain-specific investigator networks using PubMed abstracts.external icon BMC Med Inform Decis Mak 2007 Jun 20;7(1):17.
  103. Yu W, Yesupriya A, Wulf A, Qu J, Khoury MJ, Gwinn M. An open source infrastructure for managing knowledge and finding potential collaborators in a domain-specific subset of PubMed, with an example from human genome epidemiology.external icon BMC Bioinformatics. 2007 Nov 9;8:436.  Top of Page

     

    2006
  104. Brand A, Brand H, Khoury MJ, Schröder P, Zimmern R. Public health genomics in Europe (editorial). [PDF 60 KB]external iconItalian J Public Health 2006;3:5-7.
  105. Burke W, Khoury MJ, Stewart A, Zimmern R and the Bellagio working group. The path from genome-based research to population health: development of an international public health genomics network.external icon Genet Med 2006 Jul;8(7):451-8.
  106. Davis RL, Khoury MJ. A public health approach to pharmacogenomics and gene-based tests.external icon Am J Pharmacogenomics 2006 Apr;7(3):331-7.
  107. Grosse SD, Boyle C, Kenneson A, Khoury MJ, Wilfond B. From public health emergency to public health service: The implications of evolving criteria for newborn screening panels.external icon Pediatrics 2006 Mar;117(3):923-9.
  108. Grosse SD, Khoury MJ, Greene CL, Krider KS, Pollitt RJ. The epidemiology of medium chain Acyl-CoA Dehydrogenase Deficiency (MCADD): an update.external icon Genet Med 2006 Apr;8(4):205-12.
  109. Grosse SD, Khoury MJ. What is the clinical utility of genetic testing?external icon Genet Med 2006 Jul;8(7):448-50.
  110. Gwinn M, Bowen S, Khoury MJ. Genomics and public health: tools for the 21st century.external icon MMWR 2006; Dec 22; 55 (suppl 2):20-21.
  111. Gwinn ML, Khoury MJ. Expanded publishing model for genetic association studies.external icon Cancer Epi Biom Prev 2006 Jan;15(1):185.
  112. Gwinn ML, Khoury MJ. Genomics and public health in the United States: signposts on the translation highway.external icon Comm Genet 2006;9(1):21-26.
  113. Hariri S, Valdez R, Moonesinghe R, Khoury MJ. Evaluation of family history as a risk factor and screening tool for detecting undiagnosed diabetes in a nationally representative survey population.external icon Genet Med 20062006 Dec;8(12):752-9.
  114. Hariri S, Yoon PW, Qureshi N, Scheuner M, Khoury MJ. Family history of type 2 diabetes: a population-based screening tool for prevention?external icon Genet Med 2006 Feb;8(2):102-8.
  115. Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O’Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology.external icon Nat Genet. 2006 Jan;38(1):3-5.
  116. Jannssens ACJW, Khoury MJ. Predictive value of testing for multiple genetic variants in multifactorial diseases: implications for the discourse on ethical, legal and social issues.external icon Italian J Public Health 2006;3:35-41.
  117. Janssens AJW, Gwinn M, Valdez R, Venkat Narayan RM, and Khoury MJ. Predictive genetic testing for type 2 diabetes may raise unrealistic expectations.external icon British Medical Journal 2006 Sep 9;333(7567):509-10.
  118. Janssens CJW, Gwinn M, Iyer SS, Khoury MJ. Does genetic testing really improve the prediction of type 2 diabetes?external icon PLOS Medicine 2006 Feb;3(2):e114; author reply e127.
  119. Khoury MJ, Gwinn M. What role for genetics in public health and vice versa?external icon (letter to the editor) Community Genetics 2006;9(4):282; author reply 283.
  120. Khoury MJ, Gwinn M. Genomics, epidemiology and common complex diseases: let’s not throw out the baby with the bathwater.external icon Int J Epidemiol 2006 Oct;35(5):1363-4; author reply 1364-5.
  121. Khoury MJ, Jones K, Grosse SD. Quantifying the health benefits of genetic tests: the importance of a population perspective.external icon Genet Med 2006 Mar;8(3):191-5.
  122. Khoury MJ, Romero R. The integration of genomics into obstetrics and gynecology: a HuGE challenge.external icon Am J Obstet Gynecol 2006 Dec;195(6):1503-5.
  123. Lin BK, Clyne M, Walsh M, Gomez O, Yu W, Gwinn M, Khoury MJ. Tracking the epidemiology of human genes in the literature: the HuGE published literature database.external icon Am J Epidemiol 2006 Jul 1;164(1):1-4.
  124. Myers MF, Chang MH, Jorgensen C, Whitworth W, Kassim S, Litch JA, Armstrong L, Bernhardt B, Faucett WA, Irwin D, Mouchawar J, Bradley LA. Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians’ knowledge and practices.external icon Genet Med. 2006 Jun;8(6):361-70.
  125. Olney RS, Moore CA, Ojodu JA, Lindegren ML, Hannon WH. Storage and use of residual dried blood spots from state newborn screening programs.external icon J Pediatr 2006 May;148(5):618-22.
  126. Ramsey SD, Yoon PA, Moonesinghe R, Khoury MJ. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention.external icon Genet Med 2006 Sep;8(9):571-5.
  127. Scheuner MT, Whitworth WC, McGruder H, Yoon PW, Khoury MJ. Expanding the definition of positive family history for early-onset coronary heart disease.external icon Genetics in Medicine 2006 Aug;8(8):491-501.
  128. Scheuner MT, Whitworth WC, McGruder H, Yoon PW, Khoury MJ. Familial risk assessment for early-onset coronary heart disease.external icon Genetics in Medicine 2006 Aug;8(8):525-31.
  129. Smith GD, Gwinn M, Ebrahim S, Palmer LJ, Khoury MJ. Make it HuGE: human genome epidemiology reviews, population health, and the IJEexternal icon. Int J Epidemiol. 2006 Jun;35(3):507-10. Epub 2006 Apr 17. Review.
  130. Trikalinos T, Salanti G, Khoury MJ, Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations.external icon Am J Epidemiol 2006 Feb 15;163(4):300-9.
  131. Yang Q, Khoury MJ, Friedman JM, Little J, Flanders WD. How many genes underlie the occurrence of common complex diseases in the population?external icon Int J Epidemiol. 2005 Oct;34(5):1129-37  Top of Page

     

    2005
  132. Davis RL, Khoury MJ. The journey to personalized medicine.external icon Personalized Med 2005;2:1-4.
  133. Flanders WD, Khoury MJ, Yang QH, Austin H. Tests of Trait – Haplotype association when linkage phase is ambiguous, appropriate for matched case-control and cohort studies with competing risks.external icon Stat Med 2005 Aug 15;24(15):2299-316.
  134. Ioannidis JPA, Bernstein J, Boffetta P, Caporaso N, Danesh J, Edler D, Hartge P, Hunter D, Isaacs W, Jarvelin MR, Little J, Lynch H, Maraganore DM, O’Brien TR, Petersen G, Riboli E, Seminara D, Taioli E, Uitterlinden AG, Vineis P, Winn DM, Salanti G, Higgins JP, Khoury MJ. A network of investigator networks in human genome epidemiology.external icon Am J Epidemiol. 2005 Aug 15;162(4):302-4. Epub 2005 Jul 13.
  135. Khoury MJ, Davis RL, Gwinn M, Lindegren ML, Yoon PW. Response to letter to the editor by Morabia and Constantin on article: “Do we need genomic research for the prevention of common diseases with environmental causes?”external icon Am J Epidemiol 2005 May 1;161(9):799-805.
  136. Khoury MJ, Mensah GA. Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action.external icon Prevent Chron Dis 2005 Apr;2(2):A05
  137. Khoury MJ. The integration of genomics into pediatric and perinatal epidemiology: call for human genome epidemiology reviews.external icon Pediat Perinat Epidemiol 2005 May;19(3):178-80.
  138. Khoury MJ, Davis RL, Gwinn M, Lindegren ML, Yoon PW. Do we need genomic research for the prevention of common diseases with environmental causes?external icon Am J Epidemiol 2005 May 1;161(9):799-805.
  139. Khoury MJ. Genomics and public health: When can we use genome-based knowledge for population health benefits? Issues in Science & Technology 2005;21(4):15-16.
  140. Little J, Sharp L, Khoury MJ, Bradley L, Gwinn ML. The epidemiologic approach to pharmacogenomics.external icon Am J Pharmacogenomics 2005;5(1):1-20.
  141. Moore CA, Bradley L, Khoury MJ. From genetics to genomics: using gene-based medicine to prevent disease and promote health in children.external icon Semin Perinatol 2005 Jun;29(3):135-43.
  142. Ramsey SD, Burke W, Pinsky L, Clarke L, Khoury MJ. Family history screening to detect increased risk for colorectal cancer: conceptual and economic considerations.external icon Cancer Epidemiol Biomarkers Prevention 2005 Nov;14(11 Pt 1):2494-500.
  143. Yang Q, Khoury MJ, Friedman JM, Little J, Flanders WD. How many genes underlie the occurrence of common complex diseases in the population?external icon Int J Epidemiol 2005 Oct;34(5):1129-37
  144. Yoon PW. Risk prediction for common diseases. [565 KB]external icon Louisiana Law Review Dec 2005:66 (special issue):33-41.  Top of Page

     

    2004
  145. Bradley LA, CDC. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing–Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.external icon Morb Mortal Wkly Rep. 2004 Jul 16;53(27):603-6.
  146. Khoury MJ, Millikan R, Little J, Gwinn ML. The emergence of epidemiology in the genomics age.external icon Int J Epidemiol 2004 Oct;33(5):936-44.
  147. Khoury MJ. The case for a global human genome epidemiology initiative.external icon Nat Genet 2004 Oct;36(10):1027-8.
  148. Khoury MJ, Yang Q, Gwinn M, Little J, Flanders WD. An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions.external icon Genet Med 2004 Jan-Feb;6(1):38-47.
  149. Lindegren, ML, Kobrynski, L, Rasmussen, SA, Moore, CA, Grosse, SD, Vanderford, ML, Spira, TJ, McDougal, JS, Vogt, RF, Hannon, WH, Kalman, LV, Chen, B, Mattson, M, Baker, TG, Khoury, MJ. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders.external icon MMWR Recomm Rep. 2004 Jan 16;53(RR-1):1-29.
  150. McCusker M, Yoon P, Gwinn M, Malarcher AM, Neff L, Khoury MJ. Family history of heart disease and cardiovascular disease risk-reducing behaviors.external icon Genet Med 2004 May-Jun;6(3):153-8.
  151. Scheuner MT, Yoon P, Khoury MJ. Collection of family history in epidemiologic studies. Can we do better? Genet Med 2004;6:341.
  152. Scheuner MT, Yoon P, Khoury MJ. Use of family history to identify adults at increased risk for crhomics diseases and Mendelian disorders. Genet Med 2004;6:385.
  153. Scheuner MT, Yoon PW, Khoury MJ. Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and prevention.external icon Am J Med Genet 2004 Feb 15;125C(1):50-65.
  154. Scheuner MT. Clinical application of genetic risk assessment strategies for coronary artery disease: genotypes, phenotypes, and family history.external icon Prim Care. 2004 Sep;31(3):711-37, xi-xii.
  155. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genesexternal icon: reply to Janssens et al. Am J Hum Genet. 2004 Mar;74(3):588-9.
  156. Yang Q, Khoury MJ, Friedman JM, Flanders WD. How many genes does it take to make an appreciable population attributable fraction of a common disease? Presented at the Society for Epidemiologic Research, Salt Lake City, Utah, June 2004 and published in Am J Epidemiol 2004;159:S61.
  157. Yoon, PW, Scheuner MT, Gwinn M, Khoury MJ, Jorgensen C, Hariri S, Lyn S. Awareness of family health history as a risk factor for disease, United States, 2004.external icon MMWR 2004 Nov 12;53(44):1044-7.
  158. Yoon P, Scheuner MT, Khoury MJ. Research agenda for family history tools: analytic validity, clinical validity, clinical utility and ethical, legal and social implications. Genet Med 2004;6:386.  Top of Page

     

    2003
  159. Cogswell M, Gallagher ML, Steinberg KK, Caudill SP, Looker AC, Bowman BA, Gunter EW, Franks, AL, Satten GA, Khoury MJ, Grummer-Strawn LM. The HFE genotype and transferrin saturation in the United States.external icon Genet Med 2003 Jul-Aug;5(4):304-10.
  160. Haddow JE, Palomaki GE: ACCE: A model process for evaluating data on emerging genetic tests. In: Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. Khoury M, Little J, Burke W (eds.), Oxford University Press, pp. 217-233, 2003
  161. Haga SB, Khoury MJ, Burke W. Genomic profiling to promote a healthy lifestyle: not ready for prime time.external icon Nat Genet 2003 Aug;34(4):347-50.
  162. Hunt SC, Gwinn M, Adams TD. Family history assessment : strategies for prevention of cardiovascular disease.external icon Am J Prev Med 2003 Feb;24(2):136-42.
  163. Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ. The role of genetic polymorphisms in environmental health.external icon Environ Health Perspect 2003 Jun;111(8):1055-64.
  164. Khoury MJ, McCabe L, McCabe ERL. Population screening in the age of genomic medicine.external icon New Engl J Med 2003 Jan 2;348(1):50-8.
  165. Khoury MJ. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease.external icon Genet Med. 2003 Jul-Aug;5(4):261-8.
  166. Little J, Khoury MJ, Bradley L, Clyne M, Gwinn M, Lin B, Lindegren ML, Yoon P. The human genome project is complete. How do we develop a handle for the pump?external icon Am J Epidemiol 2003 Apr 15;157(8):667-73.
  167. Little J, Khoury MJ. Mendelian randomization: a new spin or real progress.external icon Lancet 2003 Sep 20;362(9388):930-1.
  168. Little JM, Gwinn M, Khoury MJ. Synergistic polymorphisms of ß1- and 2C-adrenergic receptors and the risk of congestive heart failureexternal icon (letter to the editor), New Engl J Med, 2003 Jan 30;348(5):468-70; author reply 468-70.
  169. Malarcher AM, Giles WH, Khoury MJ. Helping high-risk families: medical and public health approaches.external icon Genet Med. 2002 Jul-Aug;4(4):239-40.
  170. Morris J, Gwinn, M, Clyne M, Khoury MJ. Public knowledge regarding the role of genetic susceptibility to environmentally induced health conditions.external icon Comm Genetics 2003;6(1):22-8.
  171. Palomaki GE, Bradley LA, Richards CS, Haddow JE. Analytic validity of cystic fibrosis testing: a preliminary estimate.external icon Genet Med 2003 Jan-Feb;5(1):15-20.
  172. Palomaki GE, Haddow JE, Bradley LA, Richards CS, Stenzel TT, Grody WW. Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.external icon Genet Med 2003 Nov-Dec;5(6):440-3.
  173. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders D. Improving the Prediction of Complex Diseases by Testing for Multiple Disease-Susceptibility Genesexternal icon. American Journal of Human Genetics 2003 Mar;72(3):636-49.
  174. Yang Q, Khoury MJ, Friedman JM, Flander WD. On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction.external icon Epidemiology 2003 Mar;14(2):161-7.
  175. Yoon PW, Scheuner MT, Khoury MJ. Research priorities for evaluating family history in the prevention of common chronic diseases.external icon Am J Prev Med 2003 Feb;24(2):128-35.  Top of Page

     

    2002
  176. Burke W, Atkins D, Gwinn M, Guttmacher A, Haddow J, Lau J, Palomaki G, Press N, Richards CS, Wideroff L, Wiesner GL. Genetic test evaluation: information needs of clinicians, policy makers, and the public.external icon Am J Epidemiol. 2002 Aug 15;156(4):311-8.
  177. Gwinn ML, Khoury MJ. Research priorities for public health sciences in the post genomic era.external icon Genetics in Medicine 2002 Nov-Dec;4(6):410-1.
  178. Kalman LV, Lindegren ML, Kobrynski LJ, Buckley R, Khoury MJ. Framework for assessing impact and identifying public health interventions for severe combined immunodeficiency. Presented at the American Society for Human Genetics, Baltimore, MD, and published in Am J Hum Genet 2002;71(suppl):376.
  179. Khoury MJ. Commentary: epidemiology and the continuum from genetic research to genetic testing.external icon Am J Epidemiol 2002 Aug 15;156(4):297-9.
  180. Khoury MJ, Thrasher JF, Burke W, Gettig EA, Fridinger F, Jackson R. Challenges in communicating genetics: a public health approach.In Gostin LO (ed). Public Health Law and Ethics: a Reader. University of California Press, Berkeley, CA 2002;475-479.
  181. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson JW, Khoury MJ, et al. Reporting, appraising and integrating data on genotype prevalence and gene-disease associations.external icon Am J Epidemiol 2002 Aug 15;156(4):300-10.
  182. Malarcher A, Giles W, Khoury MJ. Helping high risk families: medical and public health approaches.external icon Genetics in Medicine 2002 Jul-Aug;4(4):239-40.
  183. Palomaki GE, Haddow JE, Bradley LA, FitzSimmons SC. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasiansexternal icon. Genet Med. 2002 Mar-Apr;4(2):90-4.
  184. Steinberg KK, Beck J, Nickerson D, Garcia-Closas M, Gallagher M, Caggana M, Reid Y, Cosentino M, Ji J, Johnson D, Hayes, RB, Earley M, Lorey F, Hannon H, Khoury, MJ, Sampson E. DNA Banking for Epidemiologic studies: a review of current practices.external icon Epidemiology 2002 May;13(3):246-54.
  185. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn ML, Faucett A, Khoury MJ. Can family history be used as a tool for public health and preventive medicine?external icon Genetics in Medicine 2002 Jul-Aug;4(4):304-10.
  186. Wang SS, O’Leary LA, FitzSimmons SC, Khoury MJ. The impact of early cystic fibrosis diagnosis on pulmonary function in children.external icon The Journal of Pediatrics 2002 Dec;141(6):804-10.  Top of Page

     

    2001
  187. Ashley-Koch A, Murphy CC, Khoury MJ, Boyle CA. Contribution of sickle cell disease to the occurrence of developmental disabilities: a population-based study.external icon Genetics in Medicine 2001 May-Jun;3(3):181-6.
  188. Beskow L, Khoury MJ, Baker T, Thrasher J. The Integration of Genomics into Public Health Research, Policy and Practice in the United States.external icon Community Genetics 2001 Jul;4(1):2-11.
  189. Beskow LM, Burke W, Merz JF, Barr PA, Terry S, Penchaszadeh VB, Gostin LO, Gwinn M, Khoury MJ. Informed consent for population-based research involving genetics.external icon JAMA 2001 Nov 14;286(18):2315-21.
  190. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond.external icon Am J Epidemiol 2001 May 15;153(10):1016-20.
  191. Brown AS, Gwinn ML, Cogswell ME, Khoury MJ. Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979-1997.external icon Genetics in Medicine 2001 Mar-Apr;3(2):109-11.
  192. Burke W, Coughlin SS, Lee NC, Weed DL, Khoury MJ. Application of population screening principles to genetic screening for adult-onset conditions.external icon Genet Test 2001 Fall;5(3):201-11.
  193. Grosse SD, Morris J, Khoury MJ. Disease-related conditions in relatives of patients with hemochromatosisexternal icon (letter). New Engl J Med 2001 May 10;344(19):1477-8.
  194. Grosse SD, Khoury MJ, Hannon HW, Boyle CA. Early diagnosis of cystic fibrosisexternal icon (letter). Pediatrics 2001 Jun;107(6):1492.
  195. Grosse S, Gwinn M. Assisting States in Assessing Newborn Screening Options.external icon Public Health Reports 2001 Mar-Apr;116(2):169-72.
  196. Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE reviewexternal icon. Am J Epidemiol. 2001 Jul 1;154(1):1-13. Review.
  197. Khoury MJ, Little J. Guidelines for submitting human genome epidemiology (HuGE) reviews to Teratology. Teratology 2001;63:62-64.
  198. Khoury MJ, Beskow L, Gwinn ML. Translation of genomic research into health careexternal icon (letter), JAMA 2001;285(19):2447-2448.
  199. Piper MA, Lindenmayer JM, Lengerich EJ, Pass KA, Brown W, Crowder WA, Khoury MJ, Baker TG, Puryear MA, Bryan JL. The role of state public health agencies in genetics and disease prevention: results of a national survey.external icon Publ Hlth Rep 2001;116(1):22-31.
  200. Steinberg KK, Cogswell ME, Change JC, Caudill SP, McQuillan GM, Bowman BA, Grummer-Strawn LM, Sampson EJ, Khoury MJ, Gallagher ML. Prevalence of C282Y and H63D mutations in the hemochromatosis gene in the United States.external icon JAMA 2001 May 2;285(17):2216-22.
  201. Steinberg, KK, Gwinn, M.,Khoury MJ. msJAMA. The role of genomics in public health and disease prevention.external icon JAMA 2001 Oct 3;286(13):1635.
  202. Wang, SS, FitzSimmons S, O’Leary LA, Rock MJ, Gwinn ML, Khoury MJ. Early diagnosis of cystic fibrosis in the newborn period and risk of P. aerugeninosa acquisition in the first ten years of life: a registry-based longitudinal study.external icon Pediatrics 2001 Feb;107(2):274-9.
  203. Wang SS, Fridinger F, Sheedy KM, Khoury MJ. Public attitudes regarding the donation and storage of blood specimens for genetic research.external icon Community Genetics 2001;491):18-26.
  204. Yoon PW, Chen B, Faucett A, Clyne M, Gwinn ML, Lubin IM, Burke W, Khoury MJ. Public health impact of genetic tests at the end of the 20th century.external icon Genet Med 2001 Nov-Dec;3(6):405-10.
  205. Yoon PW, Chen B, Faucett A, Clyne M, Gwinn ML, Lubin JW, Burke W, Khoury MJ. Public health assessment of genetic tests used in clinical medicine. Presented at the annual meeting of the American College of Medical Genetics, Miami, March 2001 and published in Genetics in Medicine 2001;3:242.  Top of Page

     

    2000
  206. Austin MA, Peyser PA, Khoury MJ. The interface of genetics and public health: research and educational challenges.external icon Annu Rev Publ Health 2000;21:81-99.
  207. Bai Y, Sherman S, Khoury MJ, Flanders WD. Bias associated with study protocols in epidemiologic studies of disease familial aggregation.external icon Am J Epidemiol 2000 May 1;151(9):927-37.
  208. Beaty TH, Khoury MJ. The interface of genetics and epidemiology.external icon Epidemiol Reviews 2000;22:120-125.
  209. Brown A, Wang SS, Gwinn ML, Khoury MJ. Public attitudes about the importance of genetic factors in determining health. Presented at the Annual Society for Human Genetics, Philadelphia, October 2000, and published in Am J Hum Genet 2000;67 S:206.
  210. Burke W, Imperatore G, McDonnell, SM, Baron RC, Khoury MJ. Contribution of different HFE genotypes to iron overload diseases: a pooled analysis.external icon Genetics in Medicine 2000 Sep-Oct;2(5):271-7.
  211. Cragan JD, Khoury MJ. Effect of prenatal diagnosis on epidemiologic studies of birth defects.external icon Epidemiology 2000 Nov;11(6):695-9.
  212. Khoury MJ, Little J. Human genome epidemiologic reviews: the beginning of something HuGE.external icon Am J Epidemiol 2000 Jan 1;151(1):2-3.
  213. Khoury MJ. Genetic susceptibility to birth defects in humans: from gene discovery to public health action.external icon Teratology 2000 Jan-Feb;61(1-2):17-20.
  214. Khoury MJ. Will genetics revolutionize medicine?external icon New Engl J Med (letter) 2000 Nov 16;343(20):1497; discussion 1498.
  215. Khoury MJ, Thrasher JF, Burke W, Gettig EA, Fridinger F, Jackson R. Challenges in communicating genetics: a public health approach.external icon Genetics in Medicine 2000 May-Jun;2(3):198-202.
  216. Khoury MJ. Genetics and Public Health in the 21st Century: A scientific foundation for using genetic information to improve health and prevent disease.external icon Presented at the annual meeting of the American College of Medical Genetics, Palm Springs, California, March, 2000 and published in Genetics in Medicine 2000;2(1):59-60.
  217. Wang SS, Fernhoff PM, Khoury MJ. Is the G985A allelic variant of medium-chain acyl-CoA dehydrogenase a risk factor for sudden infant death syndrome? A pooled analysis.external icon Pediatrics 2000 May;105(5):1175-6.
  218. Wang SS, Olne R, Harris K, Pass K, Lorey F, Choi R, Kling S, Moore C, Khoury MJ. Newborn screening for sickle cell disease: assessing program effectiveness.external icon Presented at the annual meeting of the American College of Medical Genetics, Palm Springs, California, March, 2000 and published in Genetics in Medicine 2000;2:67.
  219. Wang SS, Fernhoff PM, Grinzaid K, Ramchandran M, Franko EA, Henson M, Buehler J, Khoury MJ. Evaluating data systems from newborn screening programs, Georgia, 1998.external icon Presented at the annual meeting of the American College of Medical Genetics, Palm Springs, California, March, 2000 and published in Genetics in Medicine 2000;2:99.
  220. Yang Q, Khoury MJ, Coughlin SS, Sun F, Flanders WD. On the use of population-based registries in the clinical validation of genetic tests for disease susceptibility.external icon Genet Med. 2000 May-Jun;2(3):186-92.  Top of Page

     

    1999
  221. Coughlin SS, Khoury MJ, Steinberg KK. BRCA1 and BRCA2 gene mutations and risk of breast cancer: public health perspectives.external icon Am J Prev Med 1999 Feb;16(2):91-8.
  222. Botto LD, Moore CA, Khoury MJ, Erickson JD. Medical progress: Neural tube defects.external icon New Engl J Med 1999 Nov 11;341(20):1509-19.
  223. Gettig E, Baker T, Khoury MJ et al. Report on the Second National Conference on Genetics and Public Healthexternal icon. Presented at the second national conference on genetics and public health, Baltimore, 12/99, and published in Community Genetics 1999;2:119-136.
  224. Haddow JE, Bradley LA, Palomaki GE, Doherty RA, Bernhardt BA, Brock DJ, Cheuvront B, Cunningham GC, Donnenfeld AE, Erickson JL, Erlich HA, Ferrie RM, FitzSimmons SC, Greene MF, Grody WW, Haddow PK, Harris H, Holmes LB, Howell RR, Katz M, Klinger KW, Kloza EM, LeFevre ML, Little S, Loeben G, McGovern M, Pyeritz RE, Rowley PT, Saiki RK, Short MP, Tabone J, Wald NJ, Wilker NL, Witt DR. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.external icon Genet Med 1999 Jul-Aug;1(5):193.
  225. Khoury MJ. Human Genome Epidemiology (HuGE): Translating advances in human genetics into population-based data for medicine and public health.external icon Genetics in Medicine 1999 Mar-Apr;1(3):71-3
  226. Sun F, W. Flanders WD, Yang Q, Khoury MJ. Transmission disequilibrium test (TDT) when only one parent is available: The 1 TDT.external icon Am J Epidemiol 1999 Jul 1;150(1):97-104.
  227. Sun F, Cheng R, Flanders WD, Yang Q, Khoury MJ. Whole genome associations studies in genes affecting alcohol dependence.external icon Genet Epidemiol 1999; 17 (suppl 1): S337-S342.
  228. Sun FZ, Flanders WD, Yang GH, Zhao HY, Khoury MJ. Testing for gene-environment interaction using affected sib-pairs. American Society for Human Genetics, San Francisco, Oct 1999, and published in the Am J Hum Genet 1999;65:A15.
  229. Wang SS, Fernhoff PM, Hannon WH, Khoury MJ. Medium chain acyl coA dehydrogenase deficiency (MCADD): a HuGE review.external icon Genetics in Medicine 1999 Nov-Dec;1(7):332-9.
  230. Wang SS, Khoury MJ. An epidemiologic assessment of the relationship between the G985A medicum chain acyl-coA dehydrogenase deficiency (MCADD) allelic variant and sudden infant death syndrome.external icon Presented at the American College of Medical Genetics annual meeting, Miami, 3/1999 and published in Genetics in Medicine 1999;1:43 Jan 1.
  231. Wang SS, FitzSimmons S, Khoury MJ. Does newborn screening for cystic fibrosis reduce the risk of pseudomonas aeruginosa colonization among cystic fibrosis patients in the United States? Presented at the Society for Epidemiologic Research annual meeting, Baltimore, 6/99 and published in Am J Epidemiol 1999;149:S76.
  232. Yang Q, Khoury MJ, Sun F and Flanders WD. Case Only design to measure Gene Gene Interaction.external icon Epidemiology 1999 Mar;10(2):167-70.
  233. Yang Q, Khoury MJ, Atkinson M, Sun F, Cheng R, Flanders WD. Using case-control designs for genomewide screening for associations between genetic markers and disease susceptibility loci.external icon Genet Epidemiol 1999 (suppl 1): S779-S784.
  234. Yang Q, Sherman SL, Hassold TJ, Allran K, Taft L, Pettay D, Khoury MJ, Erickson JD, Freeman SB. Risk factors for trisomy 21: maternal cigarette smoking and oral contraceptive use in a population-based case-control studyexternal icon. Genet Med. 1999 Mar-Apr;1(3):80-8.  Top of Page

     

    1998
  235. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening.external icon JAMA 1998 Jul 8;280(2):172-8.
  236. Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health and genetics: evaluating the evidence for hemochromatosis screening.external icon Annals of Internal Medicine 1998 Dec 1;129(11):971-9.
  237. CDC Task force on Genetics and Disease Prevention. Translating advances in human genetics into public health action” a strategic plan, CDC, Atlanta, Georgia, 1997pdf icon
  238. Freeman SB, Taft LF, Dooley KJ, Allran K, Sherman SL, Hassold TJ, Khoury MJ,Saker DM. Population-based study of congenital heart defects in Down syndromeexternal icon. Am J Med Genet. 1998 Nov 16;80(3):213-7.
  239. Holtzman NA, Watson MS (eds) and the Task Force on Genetic Testing. Promoting safe and effective genetic testing in the United Statesexternal icon Johns Hopkins University Press, 1998.
  240. Khoury MJ. (editorial) Genetic and epidemiologic approaches to the search for gene-environment interaction: the case of osteoporosis.external icon Am J Epidemiol 1998 Jan 1;147(1):1-2.
  241. Khoury MJ. Genetic Epidemiology (chapter). In Rothman K. Modern Epidemiology, 2nd edition 1998.
  242. Khoury MJ, Yang QH. The future of genetic studies of complex human disorders: an epidemiologic perspective.external icon Epidemiology 1998 May;9(3):350-4.
  243. Khoury MJ, Dorman JS. The Human Genome Epidemiology Network.external icon Am J Epidemiol 1998 Jul 1;148(1):1-3.
  244. Khoury MJ, Puryear M, Thomson E, Bryan J. First annual conference on genetics and public health: Translating advances in human genetics into disease prevention and health promotion. Community Genetics 1998;1:93-108.
  245. Khoury MJ. Challenges and opportunities: a framework for the role of genetics in public health. Presented at the first annual meeting on genetics and public health, Atlanta, GA, 5/1998 and published in Community Genetics 1998;1:95.
  246. Khoury MJ. The Human Genome Epidemiology Network (HuGE Net) Presented at the first annual meeting on genetics and public health, Atlanta, GA, 5/1998 and published in Community Genetics 1998;1:100-101.
  247. O’Leary L, Khoury MJ. Impact of the human genome project on epidemiologic research. Presented at the Society for Epidemiologic Research meeting, Chicago, 6/1998 and published in the Am J Epidemiol 1998;147:S32.
  248. Roberts HE, Cragan JD, Cono J, Khoury MJ, Weatherly MR, Moore CA. Increased frequency of cystic fibrosis among infants with jejunoileal atresiaexternal icon. Am J Med Genet. 1998 Aug 6;78(5):446-9.
  249. Steinberg KK, Pernarelli J, Marcus M, Khoury MJ, Marchbanks, P, Schildkraut J. Increased risk of familial ovarian cancer among Jewish women: a population-based case-control study.external icon Genet Epidemiol 1998;15(1):51-59
  250. Sun FZ, Flanders WD, Yang QH, Khoury MJ. A new method for estimating the risk ratio in studies using case-parental control design.external icon Am J Epidemol 1998 Nov 1;148(9):902-9.
  251. Yang QH, McDonnell S, Khoury MJ. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data.external icon Annals of Internal Medicine 1998 Dec 1;129(11):946-53.
  252. Yang QH, Khoury MJ, Rodriguez C, Calle EE, Tatham LM, Flanders WD. Family history score as a predictor of breast cancer mortality: prospective data from the cancer prevention study II, United States, 1982-1991.external icon Am J Epidemiol 1998 Apr 1;147(7):652-9.
  253. Yang QH, Freeman S, Khoury MJ, et al. Maternal oral contraceptive use and the risk for maternally derived trisomy 21, by the meiotic stage of chromosome error: a population-based study. Presented at the Teratology meeting, San Diego, June, 1998 and published in Teratology 1998;57:196.  Top of Page

     

    1997
  254. Cono J, Qualls N, Khoury MJ, Hannon WH, Farrell P. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development.external icon MMWR Morb Mortal Wkly Rep. 1997 Dec 12;46(RR-16):1-24.
  255. Freeman SB, Yang QH, Khoury MJ, Sherman SL. A significant association between maternal smoking and trisomy 21 is restricted to maternal meiosis II nondysjunction. Presented at the American Society of Human Genetics meeting, Baltimore, October 1997 and published in Am J Hum Genet 1997;61:A51.
  256. Gardiner GB, Khoury MJ, Williams RR, Johnson CL, Carroll MD. Familial hypercholesterolemia (FH) diagnostic criteria: application to the 1988-94 National Health and Nutritional Examination Survey (NHANES) III data. Am J Hum Genet 1997;61:A385.
  257. Khoury MJ. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. Presented at the Annual Cystic Fibrosis Conference, Nashville, Oct 1997 and published in Ped Pulmonol 1997 (supl 14): 194.
  258. Khoury MJ. Relationship between medical genetics and public health: changing the paradigm of disease prevention and the definition of a genetic disease.external icon Am J Med Genet 1997 Aug 22;71(3):289-91.
  259. Khoury MJ. Genetic epidemiology and the future of disease prevention and public health.external icon Epidemiol Rev 1997;19:175-180.
  260. O’Leary LA, Khoury MJ, FitzSimmons SC. Impact of growth parameters in the first year of life on long term pulmonary function in children with cystic fibrosis: implications for early intervention. Presented at the American Society of Human Genetics meeting, Baltimore, October 1997 and published in Am J Hum Genet 1997;61:A109.
  261. Roberts HE, Moore CA, Fernhoff PM, Brown AL, Khoury MJ. Population study of congenital hypothyroidism and associated birth defects.external icon Am J Med Genet 1997 Jul 11;71(1):29-32.
  262. Siulc ES, Khoury MJ, Dorman JS. Educational opportunities in genetic epidemiology and molecular epidemiology: a survey of available training. Presented at Society for Epidemiologic Research, Edmonton, June 1997 and published in the Am J Epidemiol 1997;145:S9.
  263. Sun F, Yang Q, Khoury MJ. TDT and other association tests: an epidemiological view.external icon Presented at the annual International Genetic Epidemiology Society meeting, Baltimore, October 1997, and published in Genet Epidemiol 1997;14:540.
  264. Yang Q, Atkinson M, Sun F, Sherman S, Khoury MJ. The method of sib-pair linkage analysis in the context of case-control design.external icon Genet Epidemiol 1997;14(6):939-944.
  265. Yang QH, Khoury MJ, Flanders WD. Sample size requirements in case-only designs to detect gene-environment interaction.external icon Am J Epidemiol 1997;146(9):713 20.
  266. Yang Q, Khoury MJ, Mannino D. Trends and patterns of mortality associated with birth defects and genetic diseases associated mortality in the United States, 1979-1992: an analysis of multiple-cause mortality data.external icon Genet Epidemiol 1997;14:493-506.
  267. Yang QH, Khoury MJ. Evolving methods in genetic epidemiology: III. Gene-environment interaction in epidemiologic research.external icon Epidemiol Rev 1997;19:33-43.
  268. Yoon PW, Olney RS, Khoury MJ, et al. Contribution of birth defects and genetic diseases to pediatric hospitalizations: a population-based study.external icon Arch Ped & Adolesc Med 1997 Nov;151(11):1096-103.

Publications after 2009

 Top of Page